Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

Name: Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
License: Public Domain

Novartis Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic renal cell cancer, expanded access, progression despite vegf receptors

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 906092
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.